There are 3397 resources available
Panel Discussion and Interactive Q&A
Presenter: All Speakers
Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?
Resources:
Webcast
Navigating the paradigm shift: Thriving in the new era glioma care
Presenter: Ghazaleh Tabatabai
Session: Servier - Are brain cancer patients finally able to benefit from precision medicine approaches?
Resources:
Webcast
Panel discussion
Presenter: All Speakers
Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC
Resources:
Webcast
Audience Q&A
Presenter: All Speakers
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Closing Remarks
Presenter: Salvatore Siena
Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?
Resources:
Webcast
Concluding Remarks
Presenter: Javier Cortés
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Summary and close
Presenter: Ignacio Duran Martinez
Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC
Resources:
Webcast